• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.

作者信息

Isidori A M, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R, Pivonello R, Pofi R, Hasenmajer V, Venneri M A, Sbardella E, Simeoli C, Scaroni C, Lenzi A

机构信息

Department of Experimental Medicine, Sapienza University of Rome, Viale del Policlinico, 155, 00161, Rome, Italy.

Clinica Di Endocrinologia E Malattie del Metabolismo, Azienda Ospedaliero-Universitaria, Università Politecnica Delle Marche, Ancona, Italy.

出版信息

J Endocrinol Invest. 2020 Aug;43(8):1141-1147. doi: 10.1007/s40618-020-01266-w. Epub 2020 Apr 25.

DOI:10.1007/s40618-020-01266-w
PMID:32335855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7182741/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a30/7182741/a8741c8d5a57/40618_2020_1266_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a30/7182741/a8741c8d5a57/40618_2020_1266_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a30/7182741/a8741c8d5a57/40618_2020_1266_Fig1_HTML.jpg

相似文献

1
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.2019冠状病毒病感染与糖皮质激素：来自意大利内分泌学会关于肾上腺功能不全激素替代治疗专家意见的更新
J Endocrinol Invest. 2020 Aug;43(8):1141-1147. doi: 10.1007/s40618-020-01266-w. Epub 2020 Apr 25.
2
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.糖皮质激素在肾上腺皮质功能不全合并新型冠状病毒肺炎感染患者中的应用。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):472-473. doi: 10.1016/S2213-8587(20)30149-2. Epub 2020 Apr 23.
3
COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?2019冠状病毒病疫情与类固醇药物的使用：感染严重急性呼吸综合征冠状病毒2的患者是否有肾上腺功能不全的风险？
J Endocrinol Invest. 2020 Jul;43(7):1035-1036. doi: 10.1007/s40618-020-01253-1. Epub 2020 Apr 16.
4
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
5
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency.COVID-19 时期的内分泌学：肾上腺功能不全的管理。
Eur J Endocrinol. 2020 Jul;183(1):G25-G32. doi: 10.1530/EJE-20-0361.
6
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.2019冠状病毒病与内分泌疾病。欧洲内分泌学会声明。
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
7
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency.COVID-19、肾上腺、糖皮质激素和肾上腺功能不全。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Mar;165(1):1-7. doi: 10.5507/bp.2021.011. Epub 2021 Feb 4.
8
Our Response to COVID-19 as Endocrinologists and Diabetologists.作为内分泌学家和糖尿病专家，我们对新冠疫情的应对措施。
J Clin Endocrinol Metab. 2020 May 1;105(5):1299-301. doi: 10.1210/clinem/dgaa148.
9
Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic.COVID-19 大流行期间的肾上腺功能不全和糖皮质激素的应用。
Clinics (Sao Paulo). 2020 Jun 12;75:e2022. doi: 10.6061/clinics/2020/e2022. eCollection 2020.
10
Audio Interview: Tocilizumab and Covid-19.音频访谈：托珠单抗与新冠病毒
N Engl J Med. 2020 Oct 22;383(17):e114. doi: 10.1056/NEJMe2032051.

引用本文的文献

1
The Efficacy of Oral/Intravenous Corticosteroid Use in COVID-19 Patients: A Systematic Review.口服/静脉注射皮质类固醇在新冠肺炎患者中的疗效：一项系统评价
J Exp Pharmacol. 2024 Oct 1;16:321-337. doi: 10.2147/JEP.S484596. eCollection 2024.
2
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center.肢端肥大症的长期帕瑞肽治疗：一家转诊中心的广泛真实经验。
J Endocrinol Invest. 2024 Aug;47(8):1887-1901. doi: 10.1007/s40618-023-02299-7. Epub 2024 Mar 26.
3
Course of COVID-19 infection in patients with congenital adrenal hyperplasia.

本文引用的文献

1
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?慢性呼吸道疾病或其治疗是否会影响感染SARS-CoV-2的风险？
Lancet Respir Med. 2020 May;8(5):436-438. doi: 10.1016/S2213-2600(20)30167-3. Epub 2020 Apr 3.
2
Our Response to COVID-19 as Endocrinologists and Diabetologists.作为内分泌学家和糖尿病专家，我们对新冠疫情的应对措施。
J Clin Endocrinol Metab. 2020 May 1;105(5):1299-301. doi: 10.1210/clinem/dgaa148.
3
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
COVID-19 感染在先天性肾上腺皮质增生症患者中的病程。
Front Endocrinol (Lausanne). 2024 Feb 9;15:1348130. doi: 10.3389/fendo.2024.1348130. eCollection 2024.
4
Asymptomatic trigger of adrenal crisis in a patient with Sheehan syndrome: importance of timely recognition and intervention.希恩综合征患者无症状性肾上腺危象的触发因素：及时识别和干预的重要性。
BMJ Case Rep. 2023 Dec 16;16(12):e257023. doi: 10.1136/bcr-2023-257023.
5
Heat inactivation of SARS-CoV 2 enabled the measurement of salivary cortisol during COVID-19 pandemic.新冠疫情期间，通过对 SARS-CoV-2 的热失活处理，实现了对唾液皮质醇的测量。
Endocrine. 2024 Mar;83(3):775-782. doi: 10.1007/s12020-023-03597-z. Epub 2023 Nov 22.
6
Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.新型冠状病毒肺炎相关嗅觉障碍的恢复模式：现有证据分析
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4179-4189. doi: 10.1007/s12070-023-04005-8. Epub 2023 Jul 3.
7
DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing.DrugRep-HeSiaGraph：当异质双子神经网络遇到知识图谱用于药物重定位时。
BMC Bioinformatics. 2023 Oct 3;24(1):374. doi: 10.1186/s12859-023-05479-7.
8
Rationale for combined therapies in severe-to-critical COVID-19 patients.重症至危重症COVID-19患者联合治疗的基本原理。
Front Immunol. 2023 Sep 11;14:1232472. doi: 10.3389/fimmu.2023.1232472. eCollection 2023.
9
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders.COVID-19 大流行与肾上腺：糖皮质激素疾病患者的深入见解与影响
Endocrine. 2023 Oct;82(1):1-14. doi: 10.1007/s12020-023-03411-w. Epub 2023 Jun 20.
10
Impact of coronavirus disease 2019 on patients with primary adrenal insufficiency: a cross-sectional study.2019冠状病毒病对原发性肾上腺皮质功能减退症患者的影响：一项横断面研究。
Endocr Connect. 2023 Jul 12;12(8):e230122. doi: 10.1530/EC-23-0122.
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
4
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动：2019 冠状病毒病（COVID-19）危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
5
COVID-19 infection: the perspectives on immune responses.新型冠状病毒肺炎感染：免疫反应的观点
Cell Death Differ. 2020 May;27(5):1451-1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23.
6
Are my patients with rheumatic diseases at higher risk of COVID-19?我的风湿性疾病患者感染新冠病毒的风险更高吗？
Ann Rheum Dis. 2020 Jun;79(6):839-840. doi: 10.1136/annrheumdis-2020-217322. Epub 2020 Mar 22.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Real estimates of mortality following COVID-19 infection.新冠病毒感染后死亡率的实际估计值。
Lancet Infect Dis. 2020 Jul;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. Epub 2020 Mar 12.
9
Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.预防肾上腺危象：大应激与应激剂量氢化可的松给药后皮质醇反应的比较。
J Clin Endocrinol Metab. 2020 Jul 1;105(7):2262-74. doi: 10.1210/clinem/dgaa133.
10
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.